55 results
Page 2 of 3
424B5
d1i9lz
17 Nov 21
Prospectus supplement for primary offering
9:02am
424B5
a937wk
15 Nov 21
Prospectus supplement for primary offering
5:24pm
8-K
EX-99.1
upnx0v
27 Oct 20
Sobi obtains global co-development and exclusive ex-U.S. commercialization rights for systemic pegcetacoplan, a targeted C3 therapy
7:17am
424B5
dhq9slvt5emrv56
9 Jan 20
Prospectus supplement for primary offering
5:25pm
424B5
oxutimp6
7 Jan 20
Prospectus supplement for primary offering
4:19pm
S-3ASR
dw62v dpkoc6
7 Jan 20
Automatic shelf registration
4:01pm
POS AM
sp68d
4 Oct 19
Prospectus update (post-effective amendment)
4:59pm